Remarkably, the results obtained from these subgroup analyses consistently supported the robust predictive value of LINC-PINT for OS in cancer patients, as it remained unaltered and consistent across the subgroups (Table 2, Fig. S2). Here, LINC-PINT is linked to cancer.